Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Friday, March 29, 2024 · 699,677,706 Articles · 3+ Million Readers

Global Point of Care Diagnostics Market to reach 34.6 Billion by 2025 | CAGR 10.3%

Global Point of Care Diagnostics Market is expected to grow from 15.7 billion in 2017 to USD 34.6 billion by 2025, at a CAGR of 10.3% during the forecast period

Factors driving PoC diagnostics market include rising prevalence of lifestyle related diseases, increased awareness about PoC testing kits, growing VC activities & investments in the PoC diagnostics”
— Polaris Market Research

BROOKLYN, NY, UNITED STATES, February 21, 2018 /EINPresswire.com/ -- According to a study published by Polaris Market Research, The Global Point of Care Diagnostics market at USD 15.7 billion in 2017 which is anticipated to reach USD 34.6 billion by 2025 growing at a CAGR of 10.3%.

The Point of Care (PoC) diagnostics, are medical devices or tools that helps to diagnose the disease in patients’ community. The point of care diagnostics test kits are easy to handle and more accurate.

The global point of care diagnostics market is driven by rising prevalence of lifestyle related diseases, increasing government support towards awareness about PoC testing kits, increasing venture capital activities and the investments in the PoC diagnostics. Moreover, technological advancements and new product launches, and rising number of regulatory approvals for novel immunoassay techniques are the key factors increasing the market.

Polaris Market Research provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the global point of care (PoC) market, 2017-2025. This report comprises a detailed geographic distribution of the market across North America, Europe, APAC and South America, and MEA. North America is further segmented into U.S., Canada, and Mexico. Europe is divided into Germany, UK, Italy, France, and Rest of Europe. Asia-Pacific is bifurcated into China, India, Japan, and Rest of Asia-Pacific. Regionally, North America is estimated to account major share in global Point of Care (PoC) Diagnostics market in 2017 and expected to remain dominant during the forecast period. The presence of top players of point of care diagnostics in this region, and high adoption of technically advanced testing kits are the key factor responsible for the growth of market in the region. The Asia Pacific is expected to grow at high CAGR in the during the forecast period owing to increasing awareness about Point of Care (PoC) Diagnostics, increasing infectious diseases, and growing research in the region is expected to propel the growth of region over the forecast period.

Key Segmentation

As per the analysts of Polaris Market Research, the market segmentation is as below:

Segment - 1. By Product type

1.1 Cardio Metabolic Monitoring Kits
1.1.1 HBA1C Testing Kits
1.1.2 Electrolytes Testing Kits/Blood Gas
1.1.3 Cardiac Markers, and
1.1.4 LIPID Testing Kits

1.2 Infectious Disease Testing Kits
1.2.1 HIV Testing Kits
1.2.2 Influenza Testing Kits
1.2.3 Hepatitis C Testing Kits
1.2.4 Tropical Diseases Testing Kits
1.2.5 Sexually Transmitted Diseases (STDs) Testing Kits
1.2.6 Respiratory Infections Testing Kits
1.2.7 Others

1.3 Glucose Monitoring Kits

1.4 Coagulation Monitoring Kits
1.4.1 Activated Clotting Time (ACT/APTT) Testing Kits
1.4.2 PT/INR Testing Kits

1.5 Pregnancy and Fertility Testing Kits
1.5.1 Fertility Testing Kits
1.5.2 Pregnancy Testing Kits

1.6 Tumor/Cancer Markers
1.7 Urinalysis Testing Kits
1.8 Hematology Testing Kits
1.9 Cholesterol Test Strips
1.10 Drugs-Of-Abuse Testing Kits
1.11 Fecal Occult Testing Kits
1.12 Other Point Of Care Testing Kits

Segment - 2. By Mode of Prescription

2.1 OTC Testing Kits
2.2 Prescription Based Testing Kits

Segment - 3. By End User

3.1 Outpatient Healthcare Settings
3.2 Hospitals
3.3 Ambulatory Care Centers
3.4 Research Laboratories
3.5 Home Care Settings
3.6 Others

Segment - 4. Region

4.1 North America
4.1.1 U.S.
4.1.2 Canada
4.1.3 Mexico

4.2 Europe
4.2.1 Germany
4.2.2 UK
4.2.3 France
4.2.4 Italy
4.2.5 Rest of Europe

4.3 Asia-Pacific
4.3.1 China
4.3.2 India
4.3.3 Japan
4.3.4 Rest of Asia-Pacific

4.4 Latin America
4.4.1 Brazil
4.4.2 Rest of Latin America

4.5 Middle East and Africa

Competitive Landscape and Key Vendors

The global Point of Care Diagnostic market is characterized by the presence of well-diversified global and local vendors. These companies are consistently launching new products to enhance their offerings in the market. With the advancement of technologies and the product inventions, companies are innovating and introducing new customized products to cater the growing needs of the customers.

Leading Companies investigated in the Report are

• Abbott Laboratories, Inc.
• Roche Diagnostics
• Siemens AG
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• bioMerieux
• Johnson & Johnson
• Instrumentation Laboratory
• PTS Diagnostics
• Nova Biomedical


Browse other reports by Polaris Market Research:
https://www.polarismarketresearch.com

Neel
Polaris Market Research & Consulting
+16465689980
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release